Martin Taphoorn

17PUBLICATIONS
102CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)People with disabilityStudies of men and masculinitiesMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 02, 2026
Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

|Mar 20, 2025
Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 study.

Linda Dirven, Abigirl Machingura, Martin J van den Bent

|Mar 20, 2025
Perfusion MRI-based differentiation between early tumor progression and pseudoprogression in glioblastoma and its use in clinical practice.

Daniëlle van Dorth, Robert J I Croese, Feng Yan Jiang

|Jul 15, 2024
Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectives.

Florien Boele, Lena Rosenlund, Sara Nordentoft

|Apr 24, 2024
Influence of arterial transit time delays on the differentiation between tumor progression and pseudoprogression in glioblastoma by arterial spin labeling magnetic resonance imaging.

Daniëlle van Dorth, Feng Yan Jiang, Bárbara Schmitz-Abecassis

|Jan 15, 2024
Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative.

Emilie Le Rhun, Florien Boele, Giuseppe Minniti

Pageof 3

Frequent Collaborators

9 joint publications

Linda Dirven

5 joint publications

Johan A F Koekkoek

4 joint publications

Martin van den Bent

4 joint publications

Jeroen de Bresser